Symbol: |
SLC22A14
|
Description: |
solute carrier family 22, member 14 [Source:HGNC Symbol;Acc:8495]
|
Location: |
Chr3:38323785-38360066[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:235
Gene |
Compound |
Gen_sig |
Exp_pattern |
SLC22A14 |
NSC 109834 |
0.032 |
Down |
SLC22A14 |
NSC 119621 |
0.043 |
Up |
SLC22A14 |
NSC 119911 |
0.033 |
Down |
SLC22A14 |
Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) |
0.013 |
Down |
SLC22A14 |
NSC 123978 |
0.043 |
Down |
SLC22A14 |
Ethanesulfonic acid, compd. with 2-(2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy)acetanilide (1:1) |
0.01 |
Down |
SLC22A14 |
Ethanesulfonic acid, compd. with 4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)-m-hydrocinnamotoluidide (1:1) |
0.045 |
Down |
SLC22A14 |
1-Acetylthio-1-phenyl-2-nitroethane |
0.035 |
Down |
SLC22A14 |
Ethanesulfonic acid, compd. with 2-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]acetanilide (1:1) |
0.005 |
Down |
SLC22A14 |
TZT |
0.004 |
Down |
SLC22A14 |
Quinoxaline, 2,3-bis(iodomethyl)-6-methoxy- |
0.042 |
Down |
SLC22A14 |
as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-3-thio- |
0.029 |
Down |
SLC22A14 |
NSC 18320 |
0.046 |
Down |
SLC22A14 |
NSC 227265 |
0.027 |
Down |
SLC22A14 |
Buclizine Hydrochloride |
0.044 |
Down |
Expression pattern: Sensitivity / Resistance
Total:16 Current:1
[First] [Prev]  Next Last 
|
SNP:
~ Export ~
|
Records:2
SNP |
Gene |
SNP_location |
SNP_allele |
rs183691114 |
SLC22A14 |
Chr3:38359800 |
T/C |
rs73825529 |
SLC22A14 |
Chr3:38359829 |
A/G |
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:55
Total:4 Current:1
[First] [Prev]  Next Last 
|